Walter Bushnell Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 20 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -25.49%
- Profit Growth -6497.18%
- Ebitda -216.41%
- Net Worth -9.45%
- Total Assets -9.32%
About Walter Bushnell Pharmaceuticals
Walter Bushnell Pharmaceuticals Private Limited (WBPPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 December 2004 and has a history of 20 years and two months. Its registered office is in Rupnagar, Punjab, India.
The Corporate was formerly known as I S Ferro Sales Private Limited. The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Surendra Jangir and Satish Murgai serve as directors at the Company.
Company Details
- Location
Rupnagar, Punjab, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51100PB2004PTC053433
- Company No.
131144
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Dec 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Walter Bushnell Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surendra Jangir  | Director | 06-Feb-2017 | Current |
| Satish Murgai | Director | 06-Feb-2017 | Current |
Financial Performance of Walter Bushnell Pharmaceuticals.
Walter Bushnell Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 25.49% decrease. The company also saw a substantial fall in profitability, with a 6497.18% decrease in profit. The company's net worth dipped by a decrease of 9.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Walter Bushnell Pharmaceuticals?
In 2019, Walter Bushnell Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Wavin India LimitedSurendra Jangir is a mutual person
Walter Bushnell Medicines Private LimitedSurendra Jangir is a mutual person
Walter Bushnell Medisafe Private LimitedSatish Murgai is a mutual person
Walter Bushnell Drugs Private LimitedSurendra Jangir is a mutual person
Walter Bushnell Medipure Private LimitedSatish Murgai is a mutual person
Walter Bushnell Life Care Private LimitedSatish Murgai is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Walter Bushnell Pharmaceuticals?
Walter Bushnell Pharmaceuticals has a workforce of 64 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Walter Bushnell Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Walter Bushnell Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
